Recently, a novel TLR9 signaling pathway has been uncovered, which is functionally associated with the immune inflammatory response and reducing Aβ burden in Alzheimer’s disease (AD) mice. The gene discussed is TLR9; the disease is early-onset autosomal dominant Alzheimer disease.